Indefinite Delivery Contract SPE2DB25D9363

Award Date 10/8/24
Last Date to Order 12/31/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999, held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program and covers a 10-year period through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of branded and...
The federal contract IDV award is a single-award indefinite delivery contract (IDC) between the Defense Logistics Agency (DLA) and DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, awarded on June 6, 2024, provides the DLA with a vehicle to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to meet the recurring medical supply needs of military health facilities worldwide. The contract, under the SPE2DB...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The IDC, valued up to $499,999,999, is part of the SPE2DB program and runs through November 30, 2026. Under this IDC, DMS Pharmaceutical Group Inc. provides a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military...
The federal contract IDV award is a single-award indefinite delivery contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued up to $499,999,999, runs through November 30, 2026 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, covers the delivery of a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The IDC encompasses branded and generic prescription drugs, over-the-counter medications,...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at $499,999,999 and valid through November 2026, was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued up to $499,999,999 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DB program, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The IDC allows the DLA to issue firm...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The prime contractor, DMS Pharmaceutical Group Inc., is a woman-owned small business pharmaceutical wholesaler based in Illinois that specializes in providing a comprehensive range of pharmaceutical products and medical supplies to federal government agencies, particularly the Department of...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DB program, aims to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to fulfill the recurring...
  • SPE2DB25D9363
    Indefinite Delivery Contract
  • 10
    Federal Contract Awards

The federal contract indefinite delivery vehicle (IDV) award, with ID SPE2DB25D9363, is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $499,999,999, runs through December 31, 2025 and covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military health facilities worldwide under the DLA's Medical Supply Chain division.

The IDC complements DMS Pharmaceutical Group's existing prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) healthcare sites, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of military personnel and their dependents across various DoD facilities, with no set-aside designations utilized.

Generated 1/1/25, 9:05 AM